Longer-acting treatments for neovascular age-related macular degeneration—present and future
Sign Up to like & getrecommendations! Published in 2021 at "Eye"
DOI: 10.1038/s41433-020-01309-9
Abstract: The treatment of neovascular AMD (nAMD) has been revolutionized by the introduction of anti-vascular endothelial growth factor (VEGF) agents. Though, there is a tremendous gap between the outcomes in randomized clinical trials and real-world settings,… read more here.
Keywords: treatments neovascular; acting treatments; present future; neovascular age ... See more keywords